The PLATO trial’s seminal results a decade ago may not apply to all patients after a myocardial infarction; a large registry study suggests no ticagrelor benefit, perhaps even harm, in older patients.
Medscape Medical News
The PLATO trial’s seminal results a decade ago may not apply to all patients after a myocardial infarction; a large registry study suggests no ticagrelor benefit, perhaps even harm, in older patients.
Medscape Medical News